Choline-modulated arsenic trioxide-induced prolongation of cardiac repolarization in guinea pig

Basic and Clinical Pharmacology and Toxicology

Volumn 98, Issue 4, 2006, Pages 381-388

  Sun, Hong Li ^a   Chu, Wen Feng ^a   Dong, De Li ^a   Liu, Yan ^a   Bai, Yun Long ^a   Wang, Xiao Hui ^a   Zhou, Jin ^a   Yang, Bao Feng ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; CALCIUM CHANNEL L TYPE; CALCIUM ION; CHOLINE; POTASSIUM CHANNEL;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; GUINEA PIG; HEART; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; HEART VENTRICLE; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; WHOLE CELL;

ANIMALS; ARSENICALS; CALCIUM; CHOLINE; ELECTROCARDIOGRAPHY; FEMALE; GUINEA PIGS; HEART; LONG QT SYNDROME; MALE; MYOCYTES, CARDIAC; OXIDES; PATCH-CLAMP TECHNIQUES;

ANIMALIA; CAVIA PORCELLUS;

EID: 33645715807     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2006.pto_319.x     Document Type: Article

References (26)

1. i in guinea pig ventricular myocytes Acta Pharmacol. Sin. 2001 22 512 515
2. 2+ currents in the human pathophysiologic heart: a review Basic Res. Cardiol. 2002 97 111 118
3. Chiang C. E. H. N. Luk T. M. Wang P. Y. Ding Prolongation of cardiac repolarization by arsenic trioxide Blood 2002 100 2249 2252
4. Clancy C. E. R. S. Kass Defective cardiac ion channels: from mutations to clinical syndromes J. Clin. Invest. 2002 110 1075 1077
5. Dong D. L. Z. Li H. Z. Wang Z. M. Du W. H. Song B. F. Yang Acidification alters antiarrhythmic drug blockade of the ether-a-go-go-related gene (HERG) channels Basic & Clinical Pharmacology & Toxicology 2004a 94 209 212
6. + currents densities in ventricular myocytes of guinea pigs by chronic oxidant stress Acta Pharmacol. Sin. 2004b 25 751 755
7. Drolet B. C. Simard D. M. Roden Unusual effects of a QT-prolonging drug, arsenic trioxide, on cardiac potassium currents Circulation 2004 109 26 29
8. Ficker E. Y. A. Kuryshev A. T. Dennis C. Obejero-Paz L. Wang P. Hawryluk B. A. Wible A. M. Brown Mechanisms of arsenic-induced prolongation of cardiac repolarization Mol. Pharmacol. 2004 66 33 44
9. Hayes E. M. K. Pugsley W. P. Penz G. Adaikan M. J. Walker Relationship between QaT and RR intervals in rats, guinea pigs, rabbits, and primates J. Pharmacol. Toxicol. Meth. 1994 32 201 207
10. K, and HERG channels of cardiac myocytes Acta Pharmacol. Sin. 2001 22 125 131
11. Ca contributes to rate-dependent changes of action potentials in human ventricular myocytes Amer. J. Physiol. 1999 276 H98 H106
12. 2-induced apoptosis of rat myocardial cells in vitro Acta Pharmacol. Sin. 2004 39 887 891
13. Ohnishi K. H. Yoshida K. Shigeno S. Nakamura S. Fujisawa K. Naito K. Shinjo Y. Fujita H. Matsui A. Takeshita et al Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia Ann. Intern. Med. 2000 133 881 885
14. Podzuweit T. Cyclic AMP arrhythmias. Inhibition by choline esters Adv. Myocardiol. 1982 3 193 198
15. Shi H. H. Wang Z. Wang Identification and characterization of multiple subtypes of muscarinic acetylcholine receptors and their physiological functions in canine hearts Mol. Pharmacol. 1999a 55 497 507
16. + channel J. Membr. Biol. 1999b 169 55 64
17. Shi H. B. Yang D. Xu H. Wang Z. Wang Electrophysiological characterization of cardiac muscarinic acetylcholine receptors: different subtypes mediate different potassium currents Cell. Physiol. Biochem. 2003 13 59 74
18. Unnikrishnan D. J. P. Dutcher N. Varshneya R. Lucarielle M. Api S. Garl P. H. Wiernik S. Chiaramida Torsade de pointes in 3 patients with leukemia treated with arsenic trioxide Blood 2001 97 1514 1516
19. + current Brit. J. Pharmacol. 1999 126 1725 1734
20. Westervelt P. R. A. Brown D. R. Adkins H. Khoury P. Curtin D. Hurd S. M. Luger M. K. Ma T. J. Ley J. F. DiPersio Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide Blood 2001 98 266 271
21. + current in guinea pig ventricular myocytes Acta Pharmacol. Sin. 1998 19 269 272
22. + currents in mammalian ventricular myocytes Acta Pharmacol. Sin. 1999 20 961 969
23. Yang B. F. H. L. Shan D. M. Gong D. L. Dong Z. M. Du Study on the best targets of antiarrhythmic drugs J. Harbin Univ. Commer. (Nat. Sci. Ed.) 2002 18 1 5
24. 3 subtype muscarinic acetylcholine receptors Cell. Physiol. Biochem. 2005 161 163 174
25. Zhang P. S. Y. Wang L. H. Hu F. D. Shi F. Q. Qiu L. J. Hong X. Y. Han H. F. Yang Y. Z. Song Y. P. Liu et al Arsenic trioxide treated 72 cases of acute promyelocytic leukemia Chin. J. Hematol. 1996 17 58 62
26. Zhou J. R. Men X. X. Li C. F. Lü S. J. Fan B. F. Yang The effect of arsenic trioxide on QT interval prolongation during APL therapy Chin. Med. J. (Engl.) 2003 116 1764 1766